Merz completes construction of new plant and filling line 17-Sep-2019 By Ben Hargreaves Merz announces that it has completed the construction of a new plant for its botulinum neurotoxin product and unveils a ‘robot-controlled’ filling line.
NEWS IN BRIEF US FDA approves first neurotoxin for chronic sialorrhea 06-Jul-2018 By Ben Hargreaves The US FDA has approved Merz’s Xeomin as the first and only neurotoxin available to treat chronic sialorrhea.